Breaking News Instant updates and real-time market news.

KBR

KBR

$16.87

0.615 (3.78%)

, APD

Air Products

$139.30

1.34 (0.97%)

10:12
11/21/16
11/21
10:12
11/21/16
10:12

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. KBR (KBR) upgraded to Buy from Neutral at MKM Partners with analyst Daniel Scott saying the new business mix emphasizing government services and technology de-risks the model and warrants a re-rating. 2. Air Products (APD) upgraded to Buy from Hold at Argus with analyst Bill Selesky citing the spinoff of the company's Electronic Materials division, the forthcoming sale of its Performance Materials division, and other restructuring actions it has taken over the last year. 3. Fossil (FOSL) upgraded to Neutral from Underweight at Piper Jaffray with analyst Erinn Murphy saying the company has an opportunity to cut costs and its potential with hybrid watches is being underappreciated. 4. HSBC (HSBC) upgraded to Market Perform from Underperform at Bernstein. 5. Leidos (LDOS) upgraded to Outperform from Neutral at Credit Suisse with analyst Robert Springarn saying he sees further upside for Leidos driven by the IS&GS acquisition from cost synergies, deleveraging, and potential revenue synergies. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

KBR

KBR

$16.87

0.615 (3.78%)

APD

Air Products

$139.30

1.34 (0.97%)

FOSL

Fossil

$34.33

-0.52 (-1.49%)

HSBC

HSBC

$39.39

0.365 (0.94%)

LDOS

Leidos

$49.10

0.74 (1.53%)

  • 29

    Nov

KBR KBR
$16.87

0.615 (3.78%)

11/21/16
MKMP
11/21/16
UPGRADE
Target $21
MKMP
Buy
KBR upgraded to Buy from Neutral on rebranding efforts at MKM Partners
MKM Partners analyst Daniel Scott upgraded KBR to Buy and raised its price target to $21 from $15 saying the new business mix emphasizing government services and technology de-risks the model and warrants a re-rating of the valuation methodology.
11/21/16
MKMP
11/21/16
UPGRADE
MKMP
Buy
KBR upgraded to Buy from Neutral at MKM Partners
11/17/16
11/17/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Microsoft (MSFT) upgraded to Buy from Neutral at Goldman with analyst Heather Bellini saying Azure is the number two market share vendor in the cloud space, and has grown 100% or more year-over-year eight of the last 10 quarters. 2. Time Warner (TWX) upgraded to Buy from Sell at MoffettNathanson. 3. First Solar (FSLR) upgraded at JMP Securities with analyst Joseph Osha citing valuation. 4. KBR (KBR) upgraded to Buy from Neutral at BofA Merrill Lynch with analyst Anna Kaminskaya saying she expects structurally higher defense spending to drive a re-rating in KBR and sees less risk of cost overruns in the E&C business given lower reliance on fixed priced contracts and diversification into smaller sized service projects. 5. Liberty Interactive (QVCA) upgraded to Buy from Neutral at BofA Merrill Lynch with analyst Heather Balsky saying she has increased confidence in a return to positive US sales growth and expects multiple expansion as sales improve. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/17/16
11/17/16
UPGRADE
Target $20

Buy
KBR upgraded to Buy on valuation, defense spending at BofA/Merrill
As previously reported, BofA/Merrill upgraded KBR to Buy from Neutral and raised its price target to $20 from $16. Analyst Anna Kaminskaya expects structurally higher defense spending to drive a re-rating in KBR and sees less risk of cost overruns in the E&C business given lower reliance on fixed priced contracts and diversification into smaller sized service projects.
APD Air Products
$139.30

1.34 (0.97%)

09/30/16
ATLE
09/30/16
UPGRADE
ATLE
Neutral
Air Products upgraded to Neutral from Underweight at Atlantic Equities
09/23/16
JEFF
09/23/16
INITIATION
Target $26
JEFF
Hold
Versum Materials initiated with a Hold at Jefferies
Jefferies analyst Laurence Alexander started then when issued shares of Versum Materials (VSM) with a Hold rating and $26 price target. The company is being spun off from Air Products (APD).
11/21/16
ARGS
11/21/16
UPGRADE
ARGS
Buy
Air Products upgraded to Buy from Hold at Argus
11/21/16
ARGS
11/21/16
UPGRADE
ARGS
Buy
Air Products upgraded on postive moves at Argus
As noted earlier, Argus upgraded Air Products to Buy from Hold. As reasons for the upgrade, analyst Bill Selesky cited the spinoff of the company's Electronic Materials division, the forthcoming sale of its Performance Materials division, and other restructuring actions it has taken over the last year. Going forward, he expects the company to use the proceeds from asset sales to make "small to medium-sized acquisitions" and carry out stock buybacks and dividend increases. Target $159.
FOSL Fossil
$34.33

-0.52 (-1.49%)

11/16/16
11/16/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) upgraded to Buy from Hold at Deutsche Bank with analyst Bryan Kraft citing increased confidence in the company's outlook for 2017. 2. Fitbit upgraded to Sector Weight from Underweight at Pacific Crest with analyst Brad Erickson citing valuation. 3. Copa Holdings (CPA) upgraded to Buy from Neutral at Goldman with analyst Marcio Prado saying Copa is well positioned for an expected recovery cycle given more rationalized sector capacity and improved yields, and structural advantages. 4. Fossil upgraded to Overweight from Underweight at Pacific Crest with analyst Edward Yruma saying he expects the company to benefit from continuing "strong momentum in wearables." 5. Juniper (JNPR) upgraded to Conviction Buy from Buy at Goldman with analyst Simona Jankowski saying she expects new switching products to drive top and bottom-line growth in 2017 and views valuation as attractive. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/21/16
PIPR
11/21/16
UPGRADE
Target $32
PIPR
Neutral
Fossil upgraded to Neutral from Underweight at Piper Jaffray
Piper Jaffray analyst Erinn Murphy upgraded Fossil Group to Neutral and raised her price target for the shares to $32 from $23 after meeting with management. The company has opportunity to cut costs and its potential with hybrid watches is being underappreciated, Murphy tells investors in a research note.
10/31/16
10/31/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Ford (F) upgraded to Neutral from Underperform at Daiwa. 2. Chevron (CVX) upgraded to Conviction Buy from Neutral at Goldman with analyst Neil Mehta saying that after a decade of relatively flat production, the company is positioned for "strong volume improvement." 3. Fossil (FOSL) upgraded to Mixed from Negative at OTR Global with the firm saying checks indicate the response to Michael Kors (KORS) watches has been strong. 4. ADTRAN (ADTN) upgraded to Outperform from Market Perform at Northland with analyst Tim Savageaux citing the share pullback over merger concerns of its top customer CenturyLink (CTL). 5. Deere (DE) upgraded to Outperform from Neutral at Baird with analyst Mircea Dobre saying that North American large ag equipment is back to multi-decade lows and there is a sign of demand emerging outside the U.S. and there are meaningful cost savings in the pipeline. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/16/16
11/16/16
UPGRADE

Overweight
Fossil upgraded to Overweight from Underweight at Pacific Crest
Pacific Crest analyst Edward Yruma upgraded Fossil as he expects the company to benefit from continuing "strong momentum in wearables." He predicts that wearables will cause the company's financial results to reach a positive turning point, as his checks show that sales of its wearables remain strong. Truma thinks that wearables could generate 50c+ of EPS for Fossil. Target $42.
HSBC HSBC
$39.39

0.365 (0.94%)

11/17/16
NTXS
11/17/16
DOWNGRADE
NTXS
Neutral
HSBC downgraded to Neutral from Buy at Natixis
09/14/16
09/14/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. American Airlines (AAL) downgraded to Neutral from Buy at UBS with analyst Darryl Genovesi citing relative outperformance. The analyst raised his price target to $38 from $35. 2. Coach (COH) downgraded on sustainability of turnaround efforts at Morgan Stanley with analyst Kimberly Greenberger saying the company delivered on fiscal 2016 financial targets but the 10-K suggests the turnaround is unsustainable and was achieved in an "unhealthy manner." 3. Freeport McMoRan (FCX) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Evan Kurtz saying risk/reward is skewed to the downside as the stock is now pricing in $2.75/lb copper, above the firm's $2.43 average over the next 3 years. 4. HSBC (HSBC) downgraded to Neutral from Buy at UBS with the firm citing valuation following the recent rise in the shares. 5. Intersil (ISIL) downgraded to Hold from Buy at Deutsche Bank and to Neutral from Buy at B. Riley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/07/16
SBSH
11/07/16
UPGRADE
SBSH
Buy
HSBC upgraded to Buy from Neutral at Citi
11/21/16
BERN
11/21/16
UPGRADE
BERN
Market Perform
HSBC upgraded to Market Perform from Underperform at Bernstein
Bernstein analyst Chirantan Barua upgraded HSBC Holdings to Market Perform with a $30.83 price target.
LDOS Leidos
$49.10

0.74 (1.53%)

09/06/16
SBSH
09/06/16
INITIATION
Target $47
SBSH
Buy
Leidos resumed with a Buy at Citi
Citi analyst Jason Gursky resumed coverage of Leidos Holdings with a Buy rating and $47 price target.
09/07/16
ARGS
09/07/16
INITIATION
Target $54
ARGS
Buy
Leidos initiated with a Buy at Argus
Argus initiated Leidos with a Buy and $54 price target.
11/21/16
11/21/16
UPGRADE
Target $57

Outperform
Leidos upgraded to Outperform on acquisition upside at Credit Suisse
As previously reported, Credit Suisse upgraded Leidos to Outperform from Neutral and raised its price target to $57 from $40.50. Analyst Robert Springarn sees further upside for Leidos driven by the IS&GS acquisition from cost synergies, deleveraging, and potential revenue synergies.
11/21/16
FBCO
11/21/16
UPGRADE
FBCO
Outperform
Leidos upgraded to Outperform from Neutral at Credit Suisse

TODAY'S FREE FLY STORIES

QCOM

Qualcomm

$65.38

-0.05 (-0.08%)

08:42
01/16/18
01/16
08:42
01/16/18
08:42
Hot Stocks
Qualcomm sees 'serviceable addressable market' of $150B by 2020 »

Qualcomm (QCOM) stated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

HRTX

Heron Therapeutics

$21.40

-0.25 (-1.15%)

, TSRO

Tesaro

$69.59

-2.07 (-2.89%)

08:41
01/16/18
01/16
08:41
01/16/18
08:41
Recommendations
Heron Therapeutics, Tesaro analyst commentary  »

Cinvanti competitor…

HRTX

Heron Therapeutics

$21.40

-0.25 (-1.15%)

TSRO

Tesaro

$69.59

-2.07 (-2.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCOM

Qualcomm

$65.38

-0.05 (-0.08%)

, AAPL

Apple

$177.09

1.81 (1.03%)

08:41
01/16/18
01/16
08:41
01/16/18
08:41
Hot Stocks
Qualcomm announces plan for new $1B cost reduction program »

As previously reported,…

QCOM

Qualcomm

$65.38

-0.05 (-0.08%)

AAPL

Apple

$177.09

1.81 (1.03%)

AVGO

Broadcom

$264.29

0.79 (0.30%)

NXPI

NXP Semiconductors

$119.58

0.33 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 06

    Mar

AAPL

Apple

$177.09

1.81 (1.03%)

08:41
01/16/18
01/16
08:41
01/16/18
08:41
Periodicals
House Republicans call on Apple to address iPhone slowdowns, Reuters reports »

Four U.S. House…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

CIEN

Ciena

$21.94

0.06 (0.27%)

08:41
01/16/18
01/16
08:41
01/16/18
08:41
Upgrade
Ciena rating change  »

Ciena upgraded to Buy on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADTN

Adtran

08:41
01/16/18
01/16
08:41
01/16/18
08:41
Upgrade
Adtran rating change  »

Adtran upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

FNSR

Finisar

$22.74

0.48 (2.16%)

08:41
01/16/18
01/16
08:41
01/16/18
08:41
Downgrade
Finisar rating change  »

Finisar downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCOM

Qualcomm

$65.38

-0.05 (-0.08%)

, AVGO

Broadcom

$264.29

0.79 (0.30%)

08:38
01/16/18
01/16
08:38
01/16/18
08:38
Earnings
Qualcomm 'firmly committed' to FY19 adjusted EPS target of $6.75-$7.50 »

As previously reported,…

QCOM

Qualcomm

$65.38

-0.05 (-0.08%)

AVGO

Broadcom

$264.29

0.79 (0.30%)

NXPI

NXP Semiconductors

$119.58

0.33 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

MTN

Vail Resorts

$222.31

3.37 (1.54%)

08:38
01/16/18
01/16
08:38
01/16/18
08:38
Recommendations
Vail Resorts analyst commentary  »

Vail Resorts price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$42.81

-0.01 (-0.02%)

, INTC

Intel

$43.24

-0.17 (-0.39%)

08:37
01/16/18
01/16
08:37
01/16/18
08:37
Recommendations
Micron, Intel analyst commentary  »

Micron pullback a buying…

MU

Micron

$42.81

-0.01 (-0.02%)

INTC

Intel

$43.24

-0.17 (-0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 24

    Jan

  • 25

    Jan

  • 26

    Mar

ATTU

Attunity

$6.71

-0.061 (-0.90%)

08:37
01/16/18
01/16
08:37
01/16/18
08:37
Hot Stocks
Attunity wins $1.2M in additional business with Fortune 100 company »

Attunity announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

OTIV

On Track Innovations

$1.37

-0.01 (-0.72%)

08:37
01/16/18
01/16
08:37
01/16/18
08:37
Hot Stocks
On Track Innovations announces additional order of 10,000 cashless readers »

On Track Innovations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYF

Synchrony

$39.37

-0.39 (-0.98%)

08:37
01/16/18
01/16
08:37
01/16/18
08:37
Hot Stocks
Synchrony reports December charge-off rate 4.94% vs. 5.03% last month »

Reports December 30-plus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

F

Ford

$13.23

0.07 (0.53%)

08:37
01/16/18
01/16
08:37
01/16/18
08:37
Periodicals
Ford sees savings in 'every part' of business, FT reports »

Ford will have to make…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 24

    Jan

MDXG

MiMedx

$13.86

-0.08 (-0.57%)

08:36
01/16/18
01/16
08:36
01/16/18
08:36
Hot Stocks
MiMedx: First patients enrolled in Phase 3 clinical trial of AmnioFix Injectable »

MiMedx Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

UCTT

Ultra Clean

$23.22

0.47 (2.07%)

08:36
01/16/18
01/16
08:36
01/16/18
08:36
Hot Stocks
Ultra Clean sees Q1 revenue up from Q4 »

The company said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

LBCC

Long Blockchain Corp.

$5.02

-0.48 (-8.73%)

08:35
01/16/18
01/16
08:35
01/16/18
08:35
Hot Stocks
Breaking Hot Stocks news story on Long Blockchain Corp. »

Long Blockchain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRAY

Cray

08:35
01/16/18
01/16
08:35
01/16/18
08:35
Earnings
Cray sees FY17 revenue about $390M, consensus $399.96M »

Cray announced selected…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

LNG

Cheniere Energy

$54.73

0.29 (0.53%)

08:34
01/16/18
01/16
08:34
01/16/18
08:34
Hot Stocks
Cheniere Energy, Trafigura sign 15-year LNG sale and purchase agreement »

Cheniere Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

UCTT

Ultra Clean

$23.22

0.47 (2.07%)

08:34
01/16/18
01/16
08:34
01/16/18
08:34
Earnings
Ultra Clean reaffirms Q4 revenue view $240.0M-$250M, consensus $244.32M »

Sees Q4 operating margins…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

PX

Praxair

$164.15

0.34 (0.21%)

08:34
01/16/18
01/16
08:34
01/16/18
08:34
Hot Stocks
Praxair expands hydrogen supply to Motiva Port Arthur, Texas refinery »

Praxair, Inc. has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

CNCE

Concert Pharmaceuticals

$20.15

-7.53 (-27.20%)

, INCY

Incyte

$94.07

1.01 (1.09%)

08:33
01/16/18
01/16
08:33
01/16/18
08:33
Downgrade
Concert Pharmaceuticals, Incyte rating change  »

Concert Pharmaceuticals…

CNCE

Concert Pharmaceuticals

$20.15

-7.53 (-27.20%)

INCY

Incyte

$94.07

1.01 (1.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

MGM

MGM Resorts

$35.03

-0.08 (-0.23%)

, LVS

Las Vegas Sands

$71.02

0.39 (0.55%)

08:33
01/16/18
01/16
08:33
01/16/18
08:33
Recommendations
MGM Resorts, Las Vegas Sands, Wynn Resorts, Melco Resorts & Entertainment analyst commentary  »

Morgan Stanley raises…

MGM

MGM Resorts

$35.03

-0.08 (-0.23%)

LVS

Las Vegas Sands

$71.02

0.39 (0.55%)

WYNN

Wynn Resorts

$165.54

3.04 (1.87%)

MLCO

Melco Resorts & Entertainment

$27.01

-0.21 (-0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRWD

Ironwood

$15.12

0.02 (0.13%)

, AGN

Allergan

$176.05

-1.07 (-0.60%)

08:33
01/16/18
01/16
08:33
01/16/18
08:33
Hot Stocks
Ironwood, Allergan announce settlement with Sun Pharma over LINZESS »

Ironwood Pharmaceuticals…

IRWD

Ironwood

$15.12

0.02 (0.13%)

AGN

Allergan

$176.05

-1.07 (-0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 16

    Feb

  • 25

    Mar

YUMC

Yum China

$45.86

2.06 (4.70%)

08:32
01/16/18
01/16
08:32
01/16/18
08:32
Hot Stocks
Yum China sees one-time tax expense of approximately $160M in Q4 »

Yum China Holdings is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.